What DBV Technologies S.A.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 7 |
| Total trades | 1 | 10 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 10 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer | Jul 29 | Open-market sale · S | −464 | $2.70 | −$1.25K | 144,531 |
| Mohideen Pharis | Chief Medical Officer | Jan 29 | Open-market sale · S | −534 | $4.86 | −$2.6K | 144,995 |
| Epic Bpifrance | Insider | Dec 18 | Open-market sale · S | −1,292,103 | $4.19 | −$5.41M | 7,303,369 |
| Epic Bpifrance | Insider | Dec 17 | Open-market sale · S | −40,000 | $5.28 | −$211K | 8,595,472 |
| Epic Bpifrance | Insider | Dec 17 | Open-market sale · S | −2,036,990 | $4.84 | −$9.86M | 8,635,472 |
| Boucinha Virginie | Chief Financial Officer | Nov 21 | Grant / award · A | +32,000 | — | — | 70,000 |
| Trapp Kevin Michael | Chief Commercial Officer | Nov 21 | Grant / award · A | +55,000 | — | — | 55,000 |
| Mohideen Pharis | Chief Medical Officer | Nov 21 | Grant / award · A | +44,000 | — | — | 145,529 |
| Mohideen Pharis | Chief Medical Officer | Nov 21 | Open-market sale · S | −1,624 | $2.77 | −$4.5K | 101,529 |
| Mohideen Pharis | Chief Medical Officer | Nov 20 | Open-market sale · S | −6,496 | $2.88 | −$18.7K | 103,153 |
| Mohideen Pharis | Chief Medical Officer | Jul 29 | Open-market sale · S | −464 | $2.22 | −$1.03K | 109,649 |
| Mohideen Pharis | Chief Medical Officer | May 22 | Open-market sale · S | −397 | $1.84 | −$730 | 110,113 |
| Mohideen Pharis | Chief Medical Officer | Jan 30 | Open-market sale · S | −600 | $0.85 | −$510 | 110,510 |
| Mohideen Pharis | Chief Medical Officer | Nov 25 | Open-market sale · S | −565 | $0.57 | −$322 | 111,110 |
| Mohideen Pharis | Chief Medical Officer | Nov 22 | Open-market sale · S | −342 | $0.53 | −$181 | 111,675 |
| Boucinha Virginie | Chief Financial Officer | Nov 21 | Grant / award · A | +19,000 | — | — | 38,000 |
| Mohideen Pharis | Chief Medical Officer | Nov 21 | Open-market sale · S | −2,350 | $0.54 | −$1.27K | 112,017 |
| Mohideen Pharis | Chief Medical Officer | Nov 21 | Grant / award · A | +35,000 | — | — | 114,367 |
| Mohideen Pharis | Chief Medical Officer | Jul 29 | Open-market sale · S | −1,785 | $0.98 | −$1.75K | 79,367 |
| Mohideen Pharis | Chief Medical Officer | May 24 | Open-market sale · S | −660 | $1.36 | −$898 | 81,152 |
Loading...